Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9001 - 9008 of 12089 results
More Dominos Fall on the Data Protection Table
October 22, 2015| Blog| Viewpoint
Policy and Legal Implications of Implementing Renewable Energy at Scale: To DG or Not to DG – That’s The Question (Part 5 of 6)
October 21, 2015| Blog| Viewpoint
Jury Sides with DOJ in First Phase of FCA Statistical Sampling Trial
October 21, 2015| Blog| Viewpoint
ML Strategies: Medicare Cuts in the Crosshairs of a Budget Agreement?
October 21, 2015| Blog| Viewpoint
Mintz's Meghan Burke Awarded Freda Johnson Award for Trailblazing Women in Public Finance
October 21, 2015| Blog| Viewpoint
FTC Sets Berks County’s Broken Orthopedic Market
October 20, 2015| Alert| Viewpoint
What The Future Holds For Global Energy: Paul Dickerson To Speak At 40th Annual ICA Conference
October 20, 2015| Blog| Viewpoint
SCOTUS to Hear a Duo on Willful Patent Infringement
October 20, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|